Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS-Reference-Cited by-同舟云学术

Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS

Published:2009-09-10 Issue:39 Volume:106 Page:16811-16816
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Follo M. Y.,Finelli C.,Mongiorgi S.,Clissa C.,Bosi C.,Testoni N.,Chiarini F.,Ramazzotti G.,Baccarani M.,Martelli A. M.,Manzoli L.,Martinelli G.,Cocco L.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference35 articles.

1. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

2. Hypomethylation and apoptosis in 5-azacytidine–treated myeloid cells

3. Epigenetic changes in cancer

4. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

5. Further Analysis of Trials With Azacitidine in Patients With Myelodysplastic Syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear Phospholipids and Signaling: An Update of the Story;Cells;2024-04-19

2. Adding the epigenomic signature to the prognostic jigsaw of myelodysplastic neoplasm?;British Journal of Haematology;2024-04-02

3. DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study;British Journal of Haematology;2024-03-12

4. Digital methylation-specific PCR: New applications for liquid biopsy;Biomolecular Concepts;2024-01-01

5. Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen;Clinical Epigenetics;2023-10-26